FDA Class II Recall: Durepair Dura Regeneration Matrix: DUREPAIR DURA SUBSTITUTE 2… by Medtronic Neurosurgery

Key facts

What this classification means

A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. FDA still requires the recalling firm to notify affected accounts and submit status reports on the correction, though the monitoring intensity is lower than for a Class I recall. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class II, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.

What consumers should do

Facilities, clinicians, and consumers holding an affected unit or lot of Durepair Dura Regeneration Matrix: DUREPAIR DURA SUBSTITUTE 2 X 2, 61100; DUREPAIR DURA SUBSTITUTE 3 X 3, 61105; DUREPAIR DURA SUBSTITUTE 1 X 3, 61106; DUREPAIR DURA SUBSTITUTE 4 X 5, 61110; DUREPAIR DURA SUBSTITUTE 1 X 1, 61111; DURA 62100 SUBSTITUTE DUREPAIR 2X2IN NCE, 62100; DURA 62105 SUBSTITUTE DUREPAIR 3X3IN NCE, 62105; DURA 62106 SUBSTITUTE DUREPAIR 1X3IN NCE, 62106; DURA 62110 SUBSTITUTE DUREPAIR 4X5IN NCE, 62110; DURA 62111 SUBSTITUTE DUREPAIR 1X1IN NCE, 62111; DURA 62158 SUBSTITUTE DUREPAIR 5X8IN NCE, 62158. should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from Medtronic Neurosurgery. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from Medtronic Neurosurgery should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to Medtronic Neurosurgery directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.

Medtronic Neurosurgery’s FDA history

Argus HQ has recorded 9 total FDA actions tied to Medtronic Neurosurgery: 0 warning letters, 9 recalls, 0 approval records, and 0 Form 483 inspection citations.

Frequently asked questions

What is the recall class for Medtronic Neurosurgery's recall?

FDA classified this recall as Class II. A Class II recall is FDA’s middle classification. FDA assigns Class II when use of, or exposure to, the recalled product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

Why was Durepair Dura Regeneration Matrix: DUREPAIR DURA SUBSTITUT recalled?

FDA's recall record states the reason as: Dura regeneration matrix may have out-of-specification endotoxin levels due to issues with in-process and finished goods endotoxin testing, which may present clinically with signs and symptoms of an acute inflammatory process, comparable to infection.

Who should I contact about this recall?

Contact Medtronic Neurosurgery directly, or the distributor/pharmacy that supplied the product, to confirm whether your specific lot or unit is affected. Argus HQ aggregates the public FDA recall record and is not the recalling firm.

Has Medtronic Neurosurgery had other FDA recalls or enforcement actions?

Yes. Argus HQ has recorded 9 total FDA actions tied to Medtronic Neurosurgery, including 9 recalls and 0 warning letters.

Related enforcement actions

• Recall: Medtronic Neurosurgery — Class I recall: Exacta External Drainage and Monitoring System: 27581 KIT 27581 EXACTA W/EDM VC… →
• Recall: Medtronic Neurosurgery — Class I recall: Becker External Drainage and Monitoring System: 24146 EDMS 24146 BECKER NO Y-SI… →
• Recall: Medtronic Neurosurgery — Class I recall: Medtronic Duet External Drainage and Monitoring System, Interlink Injection Site… →
• Recall: Medtronic Neurosurgery — Class I recall: Medtronic Duet External Drainage and Monitoring System, SmartSite, Injection Sit… →
• Recall: Medtronic Neurosurgery — Class I recall: Medtronic Duet External Drainage and Monitoring System, SmartSite Injection Site… →
• Recall: Medtronic Neurosurgery — Class I recall: Medtronic Duet External Drainage and Monitoring System, Interlink Injection Site… →
• Recall: Medtronic Neurosurgery — Class I recall: Medtronic Duet External Drainage and Monitoring System, Interlink Injection Site… →
• Recall: Medtronic Neurosurgery — Class II recall: Medtronic REF 46915 Duet External Drainage and Monitoring system, Interlink Inje… →